<DOC>
	<DOCNO>NCT02066129</DOCNO>
	<brief_summary>The objective study determine whether , child receive low-dose inhaled corticosteroid ( ICS ) , quintuple dose inhaled corticosteroid onset symptom previously associate upper respiratory illness subsequent asthma exacerbation reduce rate severe asthma exacerbation treat oral corticosteroid .</brief_summary>
	<brief_title>Step-up Yellow Zone Inhaled Corticosteroids Prevent Exacerbations</brief_title>
	<detailed_description>The study design double-blind , parallel-group trial , include total 250 participant , age 5-11 year , diagnosis asthma history least 1 asthma exacerbation treat oral corticosteroid prior year . All participant treat 48 week open-label fluticasone 44 mcg 2 puff twice daily . During 48-week treatment period , participant receive randomize blind therapy 7 day time enter `` yellow zone '' ( onset symptom previously associate upper respiratory illness subsequent asthma exacerbation ) . Yellow zone therapy fluticasone 44 220 mcg 2 puff twice daily .</detailed_description>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Physiciandiagnosed asthma At least 1 exacerbation treat systemic ( oral injectable ) corticosteroid past 12 month Able perform reproducible spirometry Current treatment step 2 controller therapy [ lowdose ICS , leukotriene receptor antagonist ( LTRA ) ] OR current treatment step 3 controller therapy [ lowdose ICS + LABA , lowdose ICS + LTRA , medium dose ICS ] cACT score &gt; 19 , 2 prednisone treat exacerbation past 6 month , prebronchodilator FEV1 ≥ 80 % predict willing step therapy OR controller naïve qualify step 2 controller therapy [ asthma symptom SABA use &gt; 2 day per week nighttime awakening due asthma &gt; 2 night per month ] Prebronchodilator FEV1 ≥ 60 % predicted Ability willingness provide inform assent For female childbearing potential : pregnant , nonlactating , agree practice adequate birth control method . History clinical varicella varicella vaccine Systemic ( oral injectable ) corticosteroid within previous 2week period Current recent ( previous 2weeks ) use medication know significantly interact corticosteroid disposition , include limited carbamazepine , erythromycin , phenobarbital , phenytoin , rifampin , ketoconazole Presence chronic active lung disease asthma Significant medical illness asthma , include thyroid disease , diabetes mellitus , Cushing 's disease , Addison 's disease , hepatic disease , concurrent medical problem could require oral corticosteroid study A history cataract , glaucoma , medical disorder associate adverse effect corticosteroid History lifethreatening asthma exacerbation require intubation , mechanical ventilation , result hypoxic seizure More 5 prednisone treat exacerbation past 12 month More 1 hospitalization last &gt; 24 hour asthma past 12 month History adverse reaction ICS preparation ingredient Receiving hyposensitization therapy establish maintenance regimen ( On maintenance regimen ≥ 3 month ) History premature birth 35 week gestation</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Fluticasone</keyword>
</DOC>